Multiple sclerosis prevalence in Ireland: Relationship to vitamin D status and HLA genotype

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 82, Issue 3, 2011, Pages 317-322

  Lonergan, R ^a   Kinsella, K ^a   Fitzpatrick, P ^b   Brady, J ^a   Murray, B ^a   Dunne, C ^c   Hagan, R ^c   Duggan, M ^a   Jordan, S ^a   McKenna, M ^a   Hutchinson, M ^a   Tubridy, N ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c National Blood Centre Ireland   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; DNA; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DNA EXTRACTION; ENVIRONMENTAL FACTOR; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HLA SYSTEM; HUMAN; IRELAND; MALE; MULTIPLE SCLEROSIS; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; VITAMIN D DEFICIENCY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENOTYPE; GEOGRAPHY; HLA ANTIGENS; HLA-DR ANTIGENS; HUMANS; IRELAND; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PARATHYROID HORMONE; PREVALENCE; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS; YOUNG ADULT;

EID: 79951808907     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2010.220988     Document Type: Article

References (46)

1. Peltonen L. Old suspects found guilty - the first genome profile of multiple sclerosis. N Engl J Med 2007;357:927-9. (Pubitemid 47347328)
2. Dunne C, McGuigan C, Crowley J, et al. Human leucocyte antigen class II polymorphism in Irish paients with multiple sclerosis. Tissue Antigens 2006;68:257-62. (Pubitemid 44341802)
3. Ebers GC. Environmental factors and multiple sclerosis. Lancet Neurol 2008;7:268-77. (Pubitemid 351222732)
4. Gilli F, Valentino P, Caldano M, et al. Expression and regulation of IFNα/β receptor in IFNb- treated patients with multiple sclerosis. Neurology 2008;71:1940-7.
5. Acheson ED, Bachrach CA, Wright FM. Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation, and other variables. Acta Psychiatr Scand 1960;(Suppl 35):132-47.
6. Kurtzke JF, Beebe GW, Norman JE, et al. Epidemiology of multiple sclerosis in U.S. veterans: 1. Race, sex, and geographic distribution. Neurology 1979;35.
7. Miller DH, Hammond SR, McLeod JG, et al. Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental? J Neurol Neurosurg Psychiatry 1990;53:903-5.
8. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis, part I: the role of infection. Ann Neurol 2007;61:288-99. (Pubitemid 46676728)
9. Pugliatti M, Sotgiu S, Rosati G. The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg 2002;104:182-91. (Pubitemid 34792722)
10. Munger KL, Levin LI, Hollis BW, et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006;296:2832-8. (Pubitemid 44969183)
11. Dean G, Elian M. Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis. J Neurol Neurosurg Psychiatry 1997;63:565-8. (Pubitemid 27489217)
12. Hammond SR, English DR, McLeod JG. The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia. Brain 2000;123(Pt 5):968-74. (Pubitemid 30224192)
13. Beretich and Beretich. Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis. Mul Scler 2009;15:891-8.
14. McKenna MJ. Differences in vitamin D status between countries in young adults and the elderly. Am J Med 1992;93:69-77.
15. Soilu-Hanninen M, Laaksonen M, Laitinen I, et al. A longitudinal study of serum 25-hydroxyvitamin D and intact PTH levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis. J Neurol Neurosurg Psychiatry 2008;79:153-7.
16. Hayes CE, Nashold FE, Spach KM, et al. The immunological function of the vitamin D endocrine system. Mol Cell Biol 2003;49:277-300.
17. Correale J, Ysrraelit MC, Gaitan MI. Immunomodulatory effects of vitamin D in multiple sclerosis. Brain 2009;132:1146-60.
18. The Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene). Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 2009;41:824-8.
19. Auer DP, Schumann EM, Kumpfel T, et al. Seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol 2000;47:276-7. (Pubitemid 30078583)
20. Embry AF, Snowdon LR, Vieth R. Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol 2000;48:271-2. (Pubitemid 30617053)
21. Alvaro A, Hernán MA. Temporal trends in the incidence of multiple sclerosis. A systematic review. Neurology 2008;71:129-35.
22. Gray OM, McDonnell GV, Hawkins SA. Factors in the rising prevalence of multiple sclerosis in the north-east of Ireland. Mult Scler 2008;14:880-6.
23. McGuigan C, McCarthy A, Quigley C, et al. Latitudinal variation in the prevalence of multiple sclerosis in Ireland, an effect of genetic diversity. J Neurol Neurosurg Psychiatry 2004;75:572-6. (Pubitemid 38406655)
24. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis Neurology 1996;46:907-11. (Pubitemid 26134623)
25. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52. (Pubitemid 14237132)
26. Polman CH, Reingold SC, Edan GE, et al. Diagnostic Criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005;58:840-6.
27. Central Statistics Office Ireland. 2006. CSO Central Statistics Office, Skehard Road, Cork, Ireland. webmaster@cso.ie.
28. Van der Mei IAF, Ponsonby A-L, Dwyer T, et al. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. BMJ 2003;327:316.
29. McKenna MJ, Freaney R. Secondary hyperparathyroidism in the elderly: means to defining hypovitaminosis D. Osteoporos Int 1998;8(Suppl 2):S3-6.
30. Holick M. Vitamin D deficiency. N Engl J Med 2007;357:266-81.
31. Abramson JH. WINPEPI (PEPI-for-Windows): computer programs for epidemiologists. Epidemiol Perspect Innovations 2004;1:6.
32. Sarah-Michelle O, Andrew PM, Blanca MH, et al. Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis. Am J Clin Nutr 2008;88:441-7.
33. Ebers GC, Sadovnick AD, Risch NJ. A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature 1995;377:150-1.
34. Dyment DA, Yee IM, Ebers GC, et al. Multiple sclerosis in stepsiblings: recurrence risk and ascertainment. J Neurol Neurosurg Psychiatry 2006;77:258-9. (Pubitemid 43220856)
35. Ebers GC, Sadovnick AD, Dyment DA, et al. Parent-of-origin effect in multiple sclerosis: observations in halfsiblings. Lancet 2004;363:1773-4. (Pubitemid 38698382)
36. Ramagopalan SV, Maugeri NJ, Handunnetthi L, et al. Expression of the multiple sclerosis-associated MHC class ii allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet 2009;5:1-6.
37. Willer CJ, Dyment DA, Sadovnick AD, et al. Timing of birth and risk of multiple sclerosis: population based study. BMJ 2005;330:120.
38. Bayes HK. Weir CJ, O'Leary C. Timing of birth and risk of multiple sclerosis in the Scottish population. Eur Neurol 2010;63:36-40.
39. Ramagopalan SV, Link J, Byrnes JK, et al. HLA-DRB1 and month of birth in multiple sclerosis. Neurology 2009;73:2107-11.
40. Looker AC, Dawson-Hughes B, Calvo MS, et al. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 2002;30:771-7. (Pubitemid 34468001)
41. Fraga MF, Ballestar E, Paz MF, et al. Epigenetic differences arise during the lifetime of monozygotic twins. PNAS 2005;102:10604-9. (Pubitemid 41061601)
42. Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006;84:18-28.43?
43. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999;69:842-56. (Pubitemid 29205056)
44. Met Eireann 2009 (Meteorology Ireland). Met Eireann, Glasnevin Hill, Dublin 9. met.eireann@met.ie.
45. McKenna MJ, Freaney R, Byrne P, et al. Safety and efficacy of increasing wintertime vitamin D and calcium intake by milk fortification. Q J Med 1995;88:895-8. (Pubitemid 26009657)
46. Smolders J, Damoiseaux J, Menheere P, et al. Vitamin D as an immune modulator in multiple sclerosis, a review. J Neuroimmunology 2008;194:7-17.